Unveiling unexpected adverse events and haemorrhagic safety: post-marketing safety surveillance of ramucirumab from the FAERS database
Acta Clinica Belgica · 04.07.2026 · 81 (4) · 303-315
DOI: 10.1080/17843286.2026.2655844 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Clinica Belgica, online erschienen am 19.04.2026. Verfasst von Hong Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Me…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Product Surveillance, Postmarketing, Hemorrhage, Antineoplastic Agents. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province of China, Joint Funds for the Innovation of Science and Technology, Fujian Province.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian, China.
ORCID-Profile: Hong Zhou, Jinhua Zhang
Förderung
- Natural Science Foundation of Fujian Province of China
- Joint Funds for the Innovation of Science and Technology, Fujian Province
Zitieren
APA
Zhou, H., Chen, T., Wei, T., & Zhang, J. (2026). Unveiling unexpected adverse events and haemorrhagic safety: post-marketing safety surveillance of ramucirumab from the FAERS database. Acta Clinica Belgica, 81(4), 303-315. https://doi.org/10.1080/17843286.2026.2655844
Vancouver
Zhou H, Chen T, Wei T, Zhang J. Unveiling unexpected adverse events and haemorrhagic safety: post-marketing safety surveillance of ramucirumab from the FAERS database. Acta Clinica Belgica. 2026;81(4):303-315. doi:10.1080/17843286.2026.2655844
BibTeX
@article{Zhou2026,
author = {Zhou, Hong and Chen, Tingting and Wei, Ting and Zhang, Jinhua},
title = {Unveiling unexpected adverse events and haemorrhagic safety: post-marketing safety surveillance of ramucirumab from the FAERS database},
journal = {Acta Clinica Belgica},
year = {2026},
volume = {81},
number = {4},
pages = {303--315},
doi = {10.1080/17843286.2026.2655844}
}
EUVIMED